213 related articles for article (PubMed ID: 28919038)
1. Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products.
Grossman EA; Ward CC; Spradlin JN; Bateman LA; Huffman TR; Miyamoto DK; Kleinman JI; Nomura DK
Cell Chem Biol; 2017 Nov; 24(11):1368-1376.e4. PubMed ID: 28919038
[TBL] [Abstract][Full Text] [Related]
2. Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity.
Bateman LA; Nguyen TB; Roberts AM; Miyamoto DK; Ku WM; Huffman TR; Petri Y; Heslin MJ; Contreras CM; Skibola CF; Olzmann JA; Nomura DK
Chem Commun (Camb); 2017 Jun; 53(53):7234-7237. PubMed ID: 28352901
[TBL] [Abstract][Full Text] [Related]
3. Target Identification of Bioactive Covalently Acting Natural Products.
Nomura DK; Maimone TJ
Curr Top Microbiol Immunol; 2019; 420():351-374. PubMed ID: 30105423
[TBL] [Abstract][Full Text] [Related]
4. Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target.
Counihan JL; Wiggenhorn AL; Anderson KE; Nomura DK
ACS Chem Biol; 2018 Aug; 13(8):1970-1977. PubMed ID: 30004670
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?
Carratù MR; Signorile A; De Rasmo D; Reale A; Vacca A
Curr Med Chem; 2016; 23(38):4286-4296. PubMed ID: 27758717
[TBL] [Abstract][Full Text] [Related]
6. Harnessing the anti-cancer natural product nimbolide for targeted protein degradation.
Spradlin JN; Hu X; Ward CC; Brittain SM; Jones MD; Ou L; To M; Proudfoot A; Ornelas E; Woldegiorgis M; Olzmann JA; Bussiere DE; Thomas JR; Tallarico JA; McKenna JM; Schirle M; Maimone TJ; Nomura DK
Nat Chem Biol; 2019 Jul; 15(7):747-755. PubMed ID: 31209351
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells.
Berdan CA; Ho R; Lehtola HS; To M; Hu X; Huffman TR; Petri Y; Altobelli CR; Demeulenaere SG; Olzmann JA; Maimone TJ; Nomura DK
Cell Chem Biol; 2019 Jul; 26(7):1027-1035.e22. PubMed ID: 31080076
[TBL] [Abstract][Full Text] [Related]
8. Bond with Me If You Can! Natural Product, Covalent Ligand, and Reactivity-Based Probe Compete for Cysteine in PP2A Complex.
Johnson DS; Majmudar JD
Cell Chem Biol; 2017 Nov; 24(11):1317-1318. PubMed ID: 29149589
[TBL] [Abstract][Full Text] [Related]
9. Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target.
Roberts AM; Miyamoto DK; Huffman TR; Bateman LA; Ives AN; Akopian D; Heslin MJ; Contreras CM; Rape M; Skibola CF; Nomura DK
ACS Chem Biol; 2017 Apr; 12(4):899-904. PubMed ID: 28186401
[TBL] [Abstract][Full Text] [Related]
10. Functional importance of PP2A regulatory subunit loss in breast cancer.
Watt LF; Panicker N; Mannan A; Copeland B; Kahl RGS; Dun MD; Young B; Roselli S; Verrills NM
Breast Cancer Res Treat; 2017 Nov; 166(1):117-131. PubMed ID: 28744751
[TBL] [Abstract][Full Text] [Related]
11. Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK.
Xie F; Bao X; Yu J; Chen W; Wang L; Zhang Z; Xu Q
Oncotarget; 2015 Sep; 6(28):25660-76. PubMed ID: 26308070
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-Δ
Suh J; Kim DH; Kim EH; Park SA; Park JM; Jang JH; Kim SJ; Na HK; Kim ND; Kim NJ; Suh YG; Surh YJ
Cancer Lett; 2018 Jun; 424():30-45. PubMed ID: 29550515
[TBL] [Abstract][Full Text] [Related]
13. Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/adriamycin cells.
Cai F; Zhang L; Xiao X; Duan C; Huang Q; Fan C; Li J; Liu X; Li S; Liu Y
Oncol Rep; 2016 Aug; 36(2):1180-6. PubMed ID: 27350399
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Discovery and biosynthesis of natural products with anti-cancer activities.
Deng H
Anticancer Agents Med Chem; 2015; 15(3):276. PubMed ID: 25801124
[No Abstract] [Full Text] [Related]
15. Chrysophanol selectively represses breast cancer cell growth by inducing reactive oxygen species production and endoplasmic reticulum stress via AKT and mitogen-activated protein kinase signal pathways.
Park S; Lim W; Song G
Toxicol Appl Pharmacol; 2018 Dec; 360():201-211. PubMed ID: 30300626
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of protein phosphatase 2A facilitated an early stage of chemical carcinogenesis.
Ishii Y; Kuroda K; Matsushita K; Yokoo Y; Takasu S; Kijima A; Nohmi T; Ogawa K; Umemura T
Toxicol Appl Pharmacol; 2017 Dec; 336():75-83. PubMed ID: 29054680
[TBL] [Abstract][Full Text] [Related]
17. Chemoproteomic Profiling Reveals that Anticancer Natural Product Dankastatin B Covalently Targets Mitochondrial VDAC3.
Belcher BP; Machicao PA; Tong B; Ho E; Friedli J; So B; Bui H; Isobe Y; Maimone TJ; Nomura DK
Chembiochem; 2023 Jul; 24(14):e202300111. PubMed ID: 36964942
[TBL] [Abstract][Full Text] [Related]
18. Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.
Huang Q; Qin S; Yuan X; Zhang L; Ji J; Liu X; Ma W; Zhang Y; Liu P; Sun Z; Zhang J; Liu Y
Oncol Rep; 2017 Jul; 38(1):598-606. PubMed ID: 28560452
[TBL] [Abstract][Full Text] [Related]
19. NHS-Esters As Versatile Reactivity-Based Probes for Mapping Proteome-Wide Ligandable Hotspots.
Ward CC; Kleinman JI; Nomura DK
ACS Chem Biol; 2017 Jun; 12(6):1478-1483. PubMed ID: 28445029
[TBL] [Abstract][Full Text] [Related]
20. Reimagining Druggability Using Chemoproteomic Platforms.
Spradlin JN; Zhang E; Nomura DK
Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
